Shattuck Labs (STTK) Cash & Equivalents (2019 - 2026)

Shattuck Labs (STTK) has 8 years of Cash & Equivalents data on file, last reported at $90.4 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $90.4 million, up 48.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.4 million (up 48.48% YoY), and the FY2025 annual result was $54.2 million, down 5.57% from the prior year.
• Cash & Equivalents climbed to $90.4 million in Q1 2026 per STTK's latest filing, from $54.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $125.6 million in Q4 2023 and troughed at $37.9 million in Q2 2022.
• A 5-year average of $59.8 million and a median of $54.2 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 56.22% in 2022, then surged 165.15% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $47.4 million in 2022, then surged by 165.15% to $125.6 million in 2023, then slumped by 54.32% to $57.4 million in 2024, then declined by 5.57% to $54.2 million in 2025, then jumped by 66.85% to $90.4 million in 2026.
• Business Quant data shows STTK's Cash & Equivalents at $90.4 million in Q1 2026, $54.2 million in Q4 2025, and $42.5 million in Q3 2025.